| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1997;96:3897-3903.)
© 1997 American Heart Association, Inc.
Articles |
Cardiovascular and Sympathetic Effects of Nitric Oxide Inhibition at Rest and During Static Exercise in Humans
From the Department of Internal Medicine B, Centre Hospitalier Universitaire Vaudois, Lausanne (R.O., C.S., M.L., P.N., U.S.), and the Institute of Physiology, University of Lausanne (L.V., L.T.), Switzerland.
Correspondence to Dr Urs Scherrer, Department of Internal Medicine, BH 10.642, CHUV, CH-1011 Lausanne, Switzerland. E-mail Urs.Scherrer{at}chuv.hospvd.ch
Background Nitric oxide (NO) regulates vascular tone and blood pressure, and studies in animals suggest that it does so, at least in part, by modulating sympathetic neural outflow. Loss of NO-induced vasodilator tone and restraint on sympathetic vasoconstrictor outflow could lead to exaggerated vasoconstrictor and pressor responses to physical stress in humans.
Methods and Results To determine the role of NO in the modulation
of central sympathetic outflow and vascular tone at rest and during a
physical stress, we tested effects of systemic inhibition of NO
synthase by
NG-monomethyl-L-arginine
(L-NMMA) infusion (a stereospecific inhibitor of NO
synthase) on sympathetic nerve activity (microneurography), regional
vascular resistance, and blood pressure at rest and during static
handgrip. The major new findings are that (1) under resting conditions,
L-NMMA infusion, which increased mean arterial pressure by
10%, did not have any detectable effect on muscle sympathetic nerve
activity, whereas a similar increase in arterial pressure
evoked by phenylephrine infusion (an NO-independent
vasoconstrictor) decreased the rate of sympathetic nerve firing by
50%; (2) during static handgrip, the exercise-induced sympathetic
nerve responses were preserved during L-NMMA infusion but markedly
attenuated during phenylephrine infusion; and (3) the
L-NMMA–induced loss of vasodilator tone did not result in exaggerated
exercise-induced pressor and calf vasoconstrictor responses.
Conclusions These findings indicate that NO is involved in the central regulation of sympathetic outflow in humans and suggest that both neuronal and endothelial NO synthesis may contribute to the regulation of vasomotor tone.
Key Words: nervous system, autonomic • endothelium • exercise • endothelium-derived factors
This article has been cited by other articles:
 |
|
 |
|
  K. Ramasubbu, J. Estep, D. L. White, A. Deswal, and D. L. Mann Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J. Am. Coll. Cardiol., January 29, 2008; 51(4): 415 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Kaufmann, O. E. Rimoldi, T. Gnecchi-Ruscone, T. F. Luscher, and P. G. Camici Systemic nitric oxide synthase inhibition improves coronary flow reserve to adenosine in patients with significant stenoses Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2178 - H2182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sugawara, H. Komine, K. Hayashi, M. Yoshizawa, T. Otsuki, N. Shimojo, T. Miyauchi, T. Yokoi, S. Maeda, and H. Tanaka Systemic {alpha}-adrenergic and nitric oxide inhibition on basal limb blood flow: effects of endurance training in middle-aged and older adults Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1466 - H1472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gentilcore, R. Visvanathan, A. Russo, R. Chaikomin, J. E. Stevens, J. M. Wishart, A. Tonkin, M. Horowitz, and K. L. Jones Role of nitric oxide mechanisms in gastric emptying of, and the blood pressure and glycemic responses to, oral glucose in healthy older subjects Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1227 - G1232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lindqvist, A. Melcher, and P. Hjemdahl Hemodynamic and sympathoadrenal responses to mental stress during nitric oxide synthesis inhibition Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2309 - H2315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Kaufmann, O. Rimoldi, T. Gnecchi-Ruscone, R. S. Bonser, T. F. Luscher, and P. G. Camici Systemic Inhibition of Nitric Oxide Synthase Unmasks Neural Constraint of Maximal Myocardial Blood Flow in Humans Circulation, September 14, 2004; 110(11): 1431 - 1436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Stoner, M. Sabatier, K. Edge, and K. McCully Relationship between blood velocity and conduit artery diameter and the effects of smoking on vascular responsiveness J Appl Physiol, June 1, 2004; 96(6): 2139 - 2145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Harris and K. A. Matthews Interactions Between Autonomic Nervous System Activity and Endothelial Function: A Model for the Development of Cardiovascular Disease Psychosom Med, March 1, 2004; 66(2): 153 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Mallamaci, G. Tripepi, R. Maas, L. Malatino, R. Boger, and C. Zoccali Analysis of the Relationship between Norepinephrine and Asymmetric Dimethyl Arginine Levels among Patients with End-Stage Renal Disease J. Am. Soc. Nephrol., February 1, 2004; 15(2): 435 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cui, R. Zhang, T. E. Wilson, S. Witkowski, C. G. Crandall, and B. D. Levine Nitric oxide synthase inhibition does not affect regulation of muscle sympathetic nerve activity during head-up tilt Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2105 - H2110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cotter, E. Kaluski, O. Milo, A. Blatt, A. Salah, A. Hendler, R. Krakover, A. Golick, and Z. Vered LINCS: L-NAME (a NO synthase inhibitor) In the treatment of refractory Cardiogenic Shock: A prospective randomized study Eur. Heart J., July 2, 2003; 24(14): 1287 - 1295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Toda and T. Okamura The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. U. Pliquett, K. G. Cornish, J. D. Peuler, and I. H. Zucker Simvastatin Normalizes Autonomic Neural Control in Experimental Heart Failure Circulation, May 20, 2003; 107(19): 2493 - 2498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tank, A. Diedrich, C. Schroeder, M. Stoffels, G. Franke, A. M. Sharma, F. C. Luft, and J. Jordan Limited Effect of Systemic {beta}-Blockade on Sympathetic Outflow Hypertension, December 1, 2001; 38(6): 1377 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lepori, C. Sartori, H. Duplain, P. Nicod, and U. Scherrer Interaction between cholinergic and nitrergic vasodilation: a novel mechanism of blood pressure control Cardiovasc Res, September 1, 2001; 51(4): 767 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jordan, J. Tank, M. Stoffels, G. Franke, N. J. Christensen, F. C. Luft, and M. Boschmann Interaction between {beta}-Adrenergic Receptor Stimulation and Nitric Oxide Release on Tissue Perfusion and Metabolism J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2803 - 2810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bergholm, J. Westerbacka, S. Vehkavaara, A. Seppälä-Lindroos, T. Goto, and H. Yki-Järvinen Insulin Sensitivity Regulates Autonomic Control of Heart Rate Variation Independent of Body Weight in Normal Subjects J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1403 - 1409. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Martínez-Nieves and J. C. Dunbar The Effect of Diabetes and Sex on Nitric Oxide-Mediated Cardiovascular Dynamics Experimental Biology and Medicine, January 1, 2001; 226(1): 37 - 42. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. A. KINGWELL Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease FASEB J, September 1, 2000; 14(12): 1685 - 1696. [Abstract] [Full Text]
|
|
|
|
|
|
S. Chowdhary, J. C. Vaile, J. Fletcher, H. F. Ross, J. H. Coote, and J. N. Townend Nitric Oxide and Cardiac Autonomic Control in Humans Hypertension, August 1, 2000; 36(2): 264 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sartori, L. Trueb, P. Nicod, and U. Scherrer Effects of Sympathectomy and Nitric Oxide Synthase Inhibition on Vascular Actions of Insulin in Humans Hypertension, October 1, 1999; 34(4): 586 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. SARTORI, M. LEPORI, T. BUSCH, H. DUPLAIN, W. HILDEBRANDT, P. BÄRTSCH, P. NICOD, K. J. FALKE, and U. SCHERRER Exhaled Nitric Oxide Does Not Provide a Marker of Vascular Endothelial Function in Healthy Humans Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 879 - 882. [Abstract] [Full Text]
|
|
|
|
|
|
M. Lepori, C. Sartori, H. Duplain, P. Nicod, and U. Scherrer Sympathectomy potentiates the vasoconstrictor response to nitric oxide synthase inhibition in humans Cardiovasc Res, August 15, 1999; 43(3): 739 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sander, B. Chavoshan, and R. G. Victor A Large Blood Pressure–Raising Effect of Nitric Oxide Synthase Inhibition in Humans Hypertension, April 1, 1999; 33(4): 937 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Drexler Endothelium as a Therapeutic Target in Heart Failure Circulation, December 15, 1998; 98(24): 2652 - 2655. [Full Text] [PDF]
|
|